Skip to main content
SpringerLink
Log in

Levofloxacin: Penetration into Sputum and Once-Daily Treatment of Respiratory Tract Infections

  • Respiratory Tract Infections
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Une T, Fujimoto T, Sato K, et al. In vitro activity of DR-3355, an optically active ofloxacin. Antimicrob Agents Chemother 1988; 32: 1336–40

    Article  PubMed  CAS  Google Scholar 

  2. Tanaka K, Iwamoto M, Maesaki S, et al. Laboratory and clinical studies on levofloxacin. Jpn J Antibiot 1992; 45 (5): 548–56

    PubMed  CAS  Google Scholar 

  3. Nakashima M, Uematsu T, Kanamaru M, et al. Phase I study of levofloxacin, (S)-(−)ofloxacin. Jpn J Clin Pharmacol Ther 1992; 23 (2): 515–20

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Respiratory Diseases, Misyuku Hospital, Kamimeguro, 5-33-12, Meguro-ku, Tokyo 153, Japan

    Yoshitaka Nakamori, Y. Miyashita & I. Nakatani

  2. Department of Respiratory Diseases, Toranomon Hospital, Tokyo, Japan

    K. Nakata

Authors
  1. Yoshitaka Nakamori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. Miyashita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Nakatani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Nakata
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakamori, Y., Miyashita, Y., Nakatani, I. et al. Levofloxacin: Penetration into Sputum and Once-Daily Treatment of Respiratory Tract Infections. Drugs 49 (Suppl 2), 418–419 (1995). https://doi.org/10.2165/00003495-199500492-00120

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199500492-00120

Keywords

Search

Navigation